<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260216068884N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-03-15</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of two methods for preserving jawbone after the extraction of several adjacent teeth</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Efficacy of Hyaluronic Acid-Enriched Allograft for Alveolar Ridge Preservation in Multiple Adjacent Extraction Sites: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-03-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/89268</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Following tooth extraction and initial measurement of buccal bone thickness using a caliper, patients will be stratified into two distinct strata based on the baseline buccal bone thickness in the study area:
Stratum I: Buccal bone thickness &lt; 1 mm
Stratum II: Buccal bone thickness ≥ 1 mm
Within each stratum, a balanced block randomization list with block sizes of 2 (allocating one patient to each of the two groups, A+H and C, per block) will be generated by the study statistician, who is not involved in the patient selection or treatment process, using the random number generation function in Excel software. The final allocation sequence for each stratum will be recorded confidentially as "patient number → treatment group."
To ensure allocation concealment, the randomization sequence for each stratum will be placed in sequentially numbered, opaque, sealed envelopes (SNOSE). Each envelope will be identified solely by a sequential number and will be opened by the surgeon in the order of eligible patient enrollment within the corresponding stratum. The treatment team will remain unaware of the assigned group (A+H or C) until the moment the envelope is opened, and allocation will only occur after completion of baseline assessments and confirmation of eligibility criteria.
The statistical analyst will remain blinded to group assignments through the use of coded labels (e.g., Code 1 and Code 2) that bear no relation to the nature of the interventions, ensuring blinded data analysis, Blinding description: This study is designed as a single-blind randomized controlled trial. Due to the nature of the surgical intervention, the surgeon (care provider) cannot be blinded to group allocation. However, the following individuals are blinded:
Participants: Patients are not informed of their group assignment (intervention group receiving hyaluronic acid-enriched allograft or control group with natural healing). This is achieved by using identical postoperative care instructions and not disclosing the specific treatment received.
Outcome assessors: All outcome evaluations, including CBCT image analysis and soft tissue contour assessments, are performed by independent evaluators (radiologists and clinicians) who are unaware of the treatment allocation. Blinding is maintained by coding all images and digital models with participant numbers only, without any indication of group assignment.
Data analyst: The statistical analyst receives a fully coded dataset (e.g., Code 1 and Code 2 representing the groups) with no reference to the actual interventions, ensuring blinded data analysis.
The principal investigator is involved in the surgical procedure and, therefore, is not blinded to the results. Allocation concealment was ensured using sequentially numbered, opaque, sealed envelopes (SNOSE), which were opened only after confirmation of eligibility criteria and completion of baseline assessments. This blinding methodology is considered adequate to minimize detection and performance bias.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Tooth extraction of multiple adjacent teeth and subsequent alveolar bone resorption.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Allograft enriched with Hyaluronic Acid: After tooth extraction, the socket will be filled with a mixture of allograft particles and hyaluronic acid solution (Perfectha) at a 1:10 ratio. A collagen cone (Collacone) will be placed over the graft and secured with non-absorbable sutures. Intervention 2: Control group: Natural healing (no graft): After tooth extraction, the socket will be left to heal naturally with blood clot formation. No bone graft or hyaluronic acid will be placed in the socket.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Deidentified Individual Participant Data Set (IPD), Study Protocol, Statistical Analysis Plan, Informed Consent Form, Clinical Study Report, Analytic Code, and Data Dictionary

When:
Starting 6 months after publication of the main results and available for 5 years

To whom:
Available to researchers working in academic institutions who provide a methodologically sound proposal

Conditions:
For non-commercial research purposes only, with proper citation of the original study. The study principal investigator and the institutional ethics committee must approve proposals. Data should only be used for the approved research purpose and cannot be redistributed.

Where to obtain:
Available through the IRCT website (www.irct.ir) and upon request from the corresponding author at ghazal.soleimani73@gmail.com

How to obtain:
1. Submit a formal request email including a research proposal and intended use of data. 2. Review by study team (1-2 weeks). 3. Sign data sharing agreement. 4. Data delivery (1-2 weeks after agreement). Total: 3-5 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ghazal Soleimani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>TUMS School of Dentistry, North Kargar St., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55934</zip>
        <telephone>+98 21 8835 1255</telephone>
        <email>ghazal.soleimani73@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hoori Aslroosta</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>TUMS School of Dentistry, North Kargar St., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55934</zip>
        <telephone>+98 21 8835 1255</telephone>
        <email>roosta.hoori@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2></country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients requiring the extraction of multiple adjacent teeth (two or three teeth, from the right second premolar to the left second premolar region).
Aged at least 18 years.
Absence of severe systemic diseases that may affect bone healing (e.g., uncontrolled diabetes, severe osteoporosis).
No use of medications that affect bone healing (e.g., bisphosphonates).
Absence of acute periapical infection or fistula in the teeth to be extracted.
Sockets with less than 50% buccal bone dehiscence after tooth extraction.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who do not comply with treatment instructions during the study.
Patients who withdraw from the study for personal or medical reasons
Smokers.
Patients with poor oral hygiene or unwillingness to follow hygiene instructions.
Individuals belonging to vulnerable groups, including pregnant women or those lacking legal capacity or mental ability to provide informed consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Allograft enriched with Hyaluronic Acid: After tooth extraction, the socket will be filled with a mixture of allograft particles and hyaluronic acid solution (Perfectha) at a 1:10 ratio. A collagen cone (Collacone) will be placed over the graft and secured with non-absorbable sutures.</i_keyword>
      <i_keyword>Control group: Natural healing (no graft): After tooth extraction, the socket will be left to heal naturally with blood clot formation. No bone graft or hyaluronic acid will be placed in the socket.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in alveolar ridge dimensions (width and height) measured by CBCT. Timepoint: Baseline (before extraction) and 3 months after extraction. Method of measurement: Cone Beam Computed Tomography (CBCT) with image superimposition and analysis using Romexis software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Changes in soft tissue contour (volume) of the alveolar ridge. Timepoint: Baseline (before extraction) and 3 months after extraction. Method of measurement: Digital scanning and superimposition of STL files using analysis software.</sec_outcome>
      <sec_outcome>Postoperative pain intensity. Timepoint: Daily for the first week after extraction. Method of measurement: Visual Analogue Scale (VAS) from 0 to 10.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Self-funded by researcher</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-22</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences, School of Dentistry</contact_name>
        <contact_address>TUMS School of Dentistry, North Kargar St., Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
